{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:15:34Z","timestamp":1754111734280,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a rare condition with diverse clinical and pathological characteristics related to multi-organ damage. We report a case of TAFRO syndrome complicated by immune thrombocytopenia with prolonged fever and thrombocytopenia for several weeks. A 61-year-old man was transferred with sepsis caused by Enterococcus faecalis, and developed disseminated intravascular coagulation. Antibiotics treatment was initiated: however, low-grade fever and thrombocytopenia persisted despite the adequate antimicrobial treatment. Systemic edema, pleural effusion, and ascites had developed before hospitalization, and renal and liver function had deteriorated, resulting in progressive multi-organ damage. Prednisolone 40 mg\/day was initiated based on the assumption of a condition in which excessive production of inflammatory cytokines would lead to systemic deterioration and fatal organ damage. Subsequently, the fever resolved, and renal function began to normalize. However, thrombocytopenia did not show much recovery trend after Helicobacter pylori eradication therapy and initiation of thrombopoietin receptor agonists. Bone marrow biopsy results showed normal bone marrow with no malignant findings. Alternatively, significant clinical signs met the diagnostic criteria for TAFRO syndrome, and a renal biopsy revealed thrombotic microangiopathy, which is also reasonable for renal involvement in TAFRO syndrome. The use of cyclosporine remarkably corrected the thrombocytopenia. We considered this a case of TAFRO syndrome that developed after sepsis with disseminated intravascular coagulation and performed the differential diagnosis of prolonged thrombocytopenia and excluded it. Although TAFRO syndrome is a unique disease concept, diagnostic criteria may consist of nonspecific elements such as generalized edema, thrombocytopenia, persistent fever, and elevated inflammatory response, and there are many differential conditions to exclude, requiring caution in diagnosing TAFRO syndrome.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1266187","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:20:20Z","timestamp":1697181620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls"],"prefix":"10.3389","volume":"14","author":[{"given":"Hironori","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minato","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Sumitomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"B1","article-title":"Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly","volume":"51","author":"Takai","year":"2010","journal-title":"Rinsho Ketsueki"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26292","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura","year":"2021","journal-title":"Am J Hematol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2169\/internalmedicine.9622-22","article-title":"TAFRO syndrome: A disease requiring immediate medical attention","volume":"62","author":"Masaki","year":"2023","journal-title":"Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-017-0142-4","article-title":"The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis","volume":"15","author":"Wada","year":"2017","journal-title":"Thromb J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3075","article-title":"TAFRO syndrome: A disease that known is half cured","volume":"41","author":"Chen","year":"2002","journal-title":"Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.63","article-title":"Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases","volume":"53","author":"Takai","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9484-17","article-title":"TAFRO syndrome with disseminated intravascular coagulation successfully treated with tocilizumab and recombinant thrombomodulin","volume":"57","author":"Takayama","year":"2018","journal-title":"Intern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.101","article-title":"A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy","volume":"53","author":"Awano","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7340","article-title":"A case of TAFRO syndrome with DIC and neurologic and cardiac involvement","volume":"11","author":"Moy","year":"2023","journal-title":"Clin Case Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3960\/jslrt.53.79","article-title":"Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia\u2013a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity","volume":"53","author":"Masaki","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2018.12.025","article-title":"An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome","volume":"215","author":"Kurose","year":"2019","journal-title":"Pathol Res Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01489","article-title":"Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A case report and literature review","volume":"10","author":"Leurs","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06410613","article-title":"Update on membranoproliferative GN","volume":"9","author":"Masani","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-12-0761","article-title":"Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and hemolytic uremic syndrome (HUS) \/ thrombocytic thrombopenic purpura (TTP)","volume":"101","author":"Benz","year":"2009","journal-title":"Thromb Haemost"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-018-0338-x","article-title":"Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome","volume":"7","author":"Ozeki","year":"2018","journal-title":"CEN Case Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-234155","article-title":"Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology","volume":"13","author":"Simeni Njonnou","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25495","article-title":"POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am J Hematol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.102962","article-title":"Markedly elevated serum total N-terminal propeptide of type I collagen is a novel marker for the diagnosis and follow up of patients with POEMS syndrome","volume":"99","author":"Wang","year":"2014","journal-title":"Haematologica"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.236.289","article-title":"Successful treatment of TAFRO syndrome, a variant of multicentric castleman's disease, with cyclosporine A: possible pathogenetic contribution of interleukin-2","volume":"236","author":"Konishi","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221149870","article-title":"Efficacy and safety of cyclosporine-based regimens for primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"51","author":"Li","year":"2023","journal-title":"J Int Med Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1266187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:20:23Z","timestamp":1697181623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1266187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2023.1266187"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1266187","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"article-number":"1266187"}}